Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnpario Regulatory News (ANP)

Share Price Information for Anpario (ANP)

Share Price is delayed by 15 minutes
Get Live Data
520.00    5.00 (0.97%)
Bid:
510.00
Ask:
530.00
Spread: 20.00 (3.922%)
Market Cap: £85.47m
ANP Live PriceLast checked at - London Stock Exchange

Intraday Anpario Share Chart

Trading Statement

3 Feb 2014 07:00

3 February 2014

Anpario plc

(ā€œthe Companyā€ or ā€œAnparioā€)

Pre Close Trading Statement

Anpario, the international producer of natural feed additives for animal health, hygiene and nutrition, is pleased to release a Pre Close Trading Statement.

The Company expects to deliver results for the year ended 31December 2013 in line with market expectations. The results will be announced in early April 2014.

Anpario has delivered strong sales growth from all its international brands and this advance reflects the Company’s investment in expanding its sales and technical resources at its regional offices in Brazil, China and Malaysia.

The growing interest from potential customers in North America has encouraged the Company to establish a subsidiary in the United States. This new, wholly owned, subsidiary is based in South Carolina and includes sales, warehousing and distribution facilities to enable it to offer Anpario’s products throughout North America.

The United States operation complements subsidiaries already formed in Brazil and China and means the Company is now firmly located in the world’s three principal pig and poultry producing countries. These businesses serve territories which in total account for over half the world’s output of pigs and poultry and will provide a strong platform for future growth.

The balance sheet remains strong and debt free with cash balances of £4.8m at the year end.

The Company is greatly encouraged by the number of new opportunities opening up in existing and new markets as customers become increasingly aware of the performance enhancing value of Anpario’s product portfolio. Customers recognise the benefit of Anpario’s natural products that are increasingly replacing the traditional use of antibiotics. The Company’s investment in developing its product ranges backed by experienced sales teams has placed it in a strong position to maintain its growth record.

Anpario plc
David Bullen, Chief Executive Officer +44 (0)791 955 2040
Karen Prior, Group Finance Director +44 (0)1909 537 380
FinnCap
Matthew Robinson / Henrik Persson - Corporate Finance
Stephen Norcross - Corporate Broking +44 (0)20 7600 1658

Copyright Business Wire 2014

Date   Source Headline
23rd Sep 20057:00 amRNSNotice of Results
20th Sep 20054:50 pmRNSHolding(s) in Company
30th Aug 200510:03 amRNSBoard appointment
3rd Aug 200511:13 amRNSHolding(s) in Company
12th Jul 200511:15 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.